Individual versus integration of multiple components of central blood pressure and aortic stiffness in predicting cardiovascular mortality in end-stage renal diseases
- 20 January 2024
- journal article
- research article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 38 (5) , 430-436
Abstract
Aortic stiffness, measured by carotid-femoral pulse wave velocity (PWV), is a predictor of cardiovascular (CV) mortality in patients with end-stage renal disease (ESRD). Aortic stiffness increases aortic systolic and pulse pressures (cSBP, cPP) and augmentation index adjusted for a heart rate of 75 beats per minute (AIx@75). In this study, we examined if the integration of multiple components of central blood pressure and aortic stiffness (ICPS) into risk score categories could improve CV mortality prediction in ESRD. In a prospective cohort of 311 patients with ESRD on dialysis who underwent vascular assessment at baseline, 118 CV deaths occurred after a median follow-up of 3.1 years. The relationship between hemodynamic parameters and CV mortality was analyzed through Kaplan–Meier and Cox survival analysis. ICPS risk score from 0 to 5 points were calculated from points given to tertiles, and were regrouped into three risk categories (Average, High, Very-High). A strong association was found between the ICPS risk categories and CV mortality (High risk HR = 2.20, 95% CI: 1.05–4.62, P = 0.036); Very-High risk (HR = 4.44, 95% CI: 2.21–8.92, P < 0.001) as compared to the Average risk group. The Very-High risk category remained associated with CV mortality (HR = 3.55, 95% CI: 1.37–9.21, P = 0.009) after adjustment for traditional CV risk factors as compared to the Average risk group. While higher C-statistics value of ICPS categories (C: 0.627, 95% CI: 0.578–0.676, P = 0.001) was not statistically superior to PWV, cPP or AIx@75, the use of ICPS categories resulted in a continuous net reclassification index of 0.56 (95% CI: 0.07–0.99). In conclusion, integration of multiple components of central blood pressure and aortic stiffness may potentially be useful for better prediction of CV mortality in this cohort.Keywords
All Related Versions
Funding Information
- Heart and Stroke Foundation of Canada
- Kidney Foundation of Canada
- Canadian Diabetes Association
- Canadian Institute of Health Research (CIHR), New Emerging Team Grant
- Societe quebecoise d'hypertension arterielle
- Research chair in nephrology from the Fondation de l’Université Laval
This publication has 35 references indexed in Scilit:
- Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocityJournal Of Hypertension, 2012
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisNew England Journal of Medicine, 2009
- Stiffness of Capacitive and Conduit ArteriesHypertension, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Central Pulse Pressure and Mortality in End-Stage Renal DiseaseHypertension, 2002
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal DiseaseHypertension, 2001
- Arterial Wave Reflections and Survival in End-Stage Renal FailureHypertension, 2001
- Aortic Pulse Wave Velocity as a Marker of Cardiovascular Risk in Hypertensive PatientsHypertension, 1999
- Assessment of Arterial Distensibility by Automatic Pulse Wave Velocity MeasurementHypertension, 1995